Scholars Central

Case reportPublished 18 Apr 2017

Cyclic Pamidronate Treatment in Two Korean Boys with Osteogenesis Imperfecta Type I Caused by COL1A1 Mutations - Case Report

Authors: Jinkyung Kong, Ah Young Seo, Sung Yoon Cho, Dong-Kyu Jin, Heon-Seok Han

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Osteogenesis Imperfecta (OI) is a type I collagen biosynthesis disorder caused by COL1A1 mutation, and its characteristic osteoporosis is the result of an increase in bone resorption. Bisphosphonate is a useful treatment for osteoporosis due to its anti-resorptive effect, which results from a reduction of osteoclastic activity. The authors confirmed the presence of two novel COL1A1 mutations in each of two Korean boys with typical OI type I and observed clinical and radiologic improvements from successful intravenous pamidronate therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Rare Disorders: Diagnosis & Therapy
  • SubjectGenetics & Molecular Biology
  • SubjectOrthopaedics
  • BylineArticles whose byline prints “Jinkyung Kong”
  • BylineArticles whose byline prints “Ah Young Seo”
  • BylineArticles whose byline prints “Sung Yoon Cho”
  • BylineArticles whose byline prints “Dong-Kyu Jin”
  • BylineArticles whose byline prints “Heon-Seok Han”